Researchers study bed alarms for nocturna... ( MEMPHIS Tenn. Feb. 13 2013 US (...)

Researchers study bed alarms for nocturnal seizures

Date:2/13/2013

MEMPHIS, Tenn., Feb. 13, 2013 /PRNewswire-USNewswire/ -- Seizures can strike at any time. Many parents of children with epilepsy live in constant fear of that moment. Because the risk of injury or death can be decreased with monitoring or supervision, parents adjust their lives to keep their eyes constantly on their children. Some parents are forced to keep their children home from school, and others sleep in the same bed with their child. Epilepsy can take a toll on families.

(Photo: http://photos.prnewswire.com/prnh/20130213/DC60090 )

Several products are available in the marketplace that claim to reliably detect a child's seizure activity without frequent false alarms. Researchers at Le Bonheur Children's Hospital in Memphis are on the fore-front of testing these products to see which operate as promised, in order to find one that might bring the most relief to parents.

Le Bonheur's Neuroscience Institute is the only center in the United States to review all three of seizure alarms currently on the market for home use. Two of the studies are complete and published, and the third is now underway. Patients in Le Bonheur's Epilepsy Monitoring Unit are enrolled in the studies.

Sixteen-year old Becca Sharpe is one of the patients enrolled in one of the current studies. The high school junior has suffered with epilepsy since 5^th grade. Over the years, the frequency and severity of the seizures has increased, forcing her father to explore better treatment options. Becca's neurologist in Oklahoma referred her to Le Bonheur where she has access to the latest diagnostic tools in epilepsy treatment.

"As a single dad, I get up and go to work and I'm scared every minute of the day. I've driven home two or three times in the m
'/>"/>

SOURCE Le Bonheur Children's Hospital
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Leading Researchers in Vision Impairment and Blindness to Present at EURETINA Winter Meeting
2. Researchers at Scripps to Study Possible New Treatment for Parkinsons Disease
3. As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic
4. Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research
5. Researchers and Patient Advocates Honored with PhRMA Award
6. Researchers Set Record for Detecting Smallest Virus, Opening New Possibilities for Early Disease Detection
7. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
8. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
9. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
10. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
11. Researchers Evaluate Computer-based Treatment for People with Schizophrenia

Post Your Comments:

(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...

(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...

(Date:5/23/2013)... , May 23, 2013 Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...

Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3 BioElectronics and Pulsed Shortwave Therapy Make Progress 2 Cardinal Health Selects Datameer for Healthcare Data Discovery 2

[0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results [0] BioElectronics and Pulsed Shortwave Therapy Make Progress [0] Cardinal Health Selects Datameer for Healthcare Data Discovery

... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...

... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...

Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8 TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2 TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

(Date:5/24/2013)... General Data Company Inc., a leading ... data management products and solutions, has announced that ... of Durham, North Carolina, a leading manufacturer and ... clinical and research pathology marketplace. TBS will become ... specialty products and solutions to hospitals, independent labs ...

(Date:5/24/2013)... first conference of its kind, Impacts World 2013 ... decision makers from politics, business and civil society ... climate impact research across sectors and scales. , ... 2013 on May 27th, 1pm to 1:55pm and ... Speakers include: , Connie Hedegaard, EU ...

(Date:5/24/2013)... can healthy people who hear voices help schizophrenics? Finding the ... at the University of Bergen. , Researchers from the Bergen ... on how to help schizophrenics, who hear voices. The way ... voices, but who do not suffer from a mental illness. ... processes causing people to hear voices. A recent report published ...

(Date:5/24/2013)... May 24, 2013 The Icahn School ... International (CDI) exclusive license rights to commercially develop ... medicine applications. These cells are capable of further differentiation ... cardiomyocytes, endothelial cells, and vascular smooth muscle cells, and ... damaged heart tissue. , The original agreement announced in ...

(Date:5/24/2013)... The creative flair and design talent of graduating students ... Textiles and Clothing (ITC) have won applause from the ... 22 May at The Mira Hong Kong. ... various knitwear producers and yarn suppliers, the annual Knitwear ... from 20 graduating students majoring in knitwear design. The ...

Breaking Medicine News(10 mins):Health News:General Data Acquires Triangle Biomedical Sciences 2 Health News:General Data Acquires Triangle Biomedical Sciences 3 Health News:Help at hand for schizophrenics 2 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4 Health News:PolyU Stages Knitwear Fashion Show 2

[0] General Data Acquires Triangle Biomedical Sciences [0] Impacts conference on climate change effects [0] Help at hand for schizophrenics [0] Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles [0] PolyU Stages Knitwear Fashion Show

... from Strong International Performance and InLight ... Equipment Sales, ... personal and environmental radiation,monitoring, today reported record performance in its first fiscal ... -- Revenue reached a record $21.8 million on higher international revenues ...

... Sensitive Customer Health Care ... Data on Laptops and Desktops, ... global,leader in enterprise data protection, today announced that Payformance,Health, a ... Funds Transfer (EFT) and Electronic Remittance,Advice (ERA) services, has standardized ...

... Enables Improved Patient Safety and Office ... ... Jan. 31 Kryptiq, the leading provider,of next generation healthcare ... A four-hospital,organization with 55 physician clinics in the Springfield, MO ...

... 31 Oncology focused,biopharmaceutical product development company ... finalized its Rhitol(TM) Phase II clinical trial,with ... treatment cycle. Rhitol(TM),is evaluated as treatment for ... (GvHD) intolerant or resistant to standard immunosuppressive,treatment., ...

... ... -- Revises 2008 EPS Guidance Primarily to Reflect the Sale of Medical ... Imaging, -- Reaffirms Expected Non-GAAP EPS CAGR of at ... Through 2010, Subject to Certain Assumptions, -- Completes Sale of Medical Imaging Business, Reports as Discontinued, ...

... 31, 2008 The Procter &,Gamble Company (NYSE: ... to,$21.6 billion for the quarter. Sales were up behind ... and double-digit organic,growth in developing regions. Organic volume increased ... the quarter. Diluted earnings per,share increased 17 percent to ...

Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security CoxHealth Deploys Kryptiq ePrescribing Solution Kiadis Pharma Announces Successful Completion of Rhitol(TM) Phase II Clinical Study Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company

Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....

Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....

Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....

5 mm jaws with teeth provide secure fixation of occular structures....

Medicine Products:

Pierse Type Fine Skeleton Forceps Pierse Type Micro Skeleton Forceps Pierse Type Colibri Forceps Green Straight Fixation Forceps